English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [511]
News [1917]
Articles [127]
Editorials [6]
Conferences [57]
elearning [17]
ASCO GI 2022: Ripretinib demonstrates comparable efficacy and fewer side effects compared to sunitinib in patients with GIST previously treated with imatinib
ASCO GI 2022: Ripretinib demonstrates comparable efficacy and fewer side effects compared to sunitin...
Young-onset cancers in Australia rise, and experts don't know why
Young-onset cancers in Australia rise, and experts don't know why
Mouse study identifies bacterial protein associated with colorectal cancers
Mouse study identifies bacterial protein associated with colorectal cancers
Study sets framework for precision surveillance of colorectal cancer
Study sets framework for precision surveillance of colorectal cancer
Pembrolizumab combination as a potentially transformative treatment for HER2-positive gastric cancer
Pembrolizumab combination as a potentially transformative treatment for HER2-positive gastric cancer
Primary care clinicians adjust recommendations for colorectal cancer screening to accommodate patient needs and preferences
Primary care clinicians adjust recommendations for colorectal cancer screening to accommodate patien...
Improving drug options for colorectal cancer patients
Improving drug options for colorectal cancer patients
Nivolumab for the adjuvant treatment of oesophageal carcinoma
Nivolumab for the adjuvant treatment of oesophageal carcinoma
Bowel cancer patients at high risk of clinical levels of depression
Bowel cancer patients at high risk of clinical levels of depression
How has the COVID-19 pandemic impacted the diagnosis of new cancers?
How has the COVID-19 pandemic impacted the diagnosis of new cancers?
<1234567...192>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307